Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

2.

Visceral leishmaniasis: experimental models for drug discovery.

Gupta S; Nishi.

Indian J Med Res. 2011 Jan;133:27-39. Review.

3.

Antiparasitic chemotherapy: tinkering with the purine salvage pathway.

Datta AK, Datta R, Sen B.

Adv Exp Med Biol. 2008;625:116-32. doi: 10.1007/978-0-387-77570-8_10. Review.

PMID:
18365663
4.

Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.

Selvapandiyan A, Dey R, Gannavaram S, Solanki S, Salotra P, Nakhasi HL.

Vaccine. 2014 Jun 30;32(31):3895-901. doi: 10.1016/j.vaccine.2014.05.009. Epub 2014 May 14. Review.

PMID:
24837513
5.

Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.

Don R, Ioset JR.

Parasitology. 2014 Jan;141(1):140-6. doi: 10.1017/S003118201300142X. Epub 2013 Aug 28. Review. Erratum in: Parasitology. 2014 Jan;141(1):147.

PMID:
23985066
6.

Novel approaches for the identification of inhibitors of leishmanial dipeptidylcarboxypeptidase.

Goyal N.

Expert Opin Drug Discov. 2013 Sep;8(9):1127-34. doi: 10.1517/17460441.2013.807247. Epub 2013 Jun 8. Review.

PMID:
23745836
7.

A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Mears ER, Modabber F, Don R, Johnson GE.

PLoS Negl Trop Dis. 2015 Sep 3;9(9):e0003889. doi: 10.1371/journal.pntd.0003889. eCollection 2015. Review.

8.

Protease inhibitors in potential drug development for Leishmaniasis.

Das P, Alam MN, Paik D, Karmakar K, De T, Chakraborti T.

Indian J Biochem Biophys. 2013 Oct;50(5):363-76. Review.

PMID:
24772958
9.

Imaging host-Leishmania interactions: significance in visceral leishmaniasis.

Forestier CL.

Parasite Immunol. 2013 Sep-Oct;35(9-10):256-66. doi: 10.1111/pim.12044. Review.

10.

Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.

Cruz AK, de Toledo JS, Falade M, Terrão MC, Kamchonwongpaisan S, Kyle DE, Uthaipibull C.

Curr Drug Targets. 2009 Mar;10(3):178-92. Review.

PMID:
19275555
11.

A comprehensive review of patented antileishmanial agents.

Rama M, Kumar NV, Balaji S.

Pharm Pat Anal. 2015 Jan;4(1):37-56. doi: 10.4155/ppa.14.55. Review.

PMID:
25565159
12.
13.

Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process.

Forestier CL, Späth GF, Prina E, Dasari S.

Microb Pathog. 2015 Nov;88:103-8. doi: 10.1016/j.micpath.2014.10.012. Epub 2014 Oct 31. Review.

PMID:
25448129
14.

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

Vanaerschot M, Decuypere S, Berg M, Roy S, Dujardin JC.

Crit Rev Microbiol. 2013 Nov;39(4):384-94. doi: 10.3109/1040841X.2012.716818. Epub 2012 Sep 6. Review.

PMID:
22950457
15.

Natural killer cells in experimental and human leishmaniasis.

Bogdan C.

Front Cell Infect Microbiol. 2012 May 29;2:69. doi: 10.3389/fcimb.2012.00069. eCollection 2012. Review.

16.

Modes of action of Leishmanicidal antimicrobial peptides.

Marr AK, McGwire BS, McMaster WR.

Future Microbiol. 2012 Sep;7(9):1047-59. doi: 10.2217/fmb.12.85. Review.

PMID:
22953706
17.
18.

Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania.

de Mendonça SC, Cysne-Finkelstein L, Matos DC.

Front Immunol. 2015 Oct 13;6:524. doi: 10.3389/fimmu.2015.00524. eCollection 2015. Review.

19.

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.

Roatt BM, Aguiar-Soares RD, Coura-Vital W, Ker HG, Moreira Nd, Vitoriano-Souza J, Giunchetti RC, Carneiro CM, Reis AB.

Front Immunol. 2014 Jun 13;5:272. doi: 10.3389/fimmu.2014.00272. eCollection 2014. Review.

20.

Morinda citrifolia Linn. fruit (Noni) juice induces an increase in NO production and death of Leishmania amazonensis amastigotes in peritoneal macrophages from BALB/c.

Almeida-Souza F, de Souza Cda S, Taniwaki NN, Silva JJ, de Oliveira RM, Abreu-Silva AL, Calabrese Kda S.

Nitric Oxide. 2016 Aug 31;58:51-8. doi: 10.1016/j.niox.2016.06.004. Epub 2016 Jun 18. Review.

PMID:
27328771
Items per page

Supplemental Content

Write to the Help Desk